FRIDAY, July 23, 2021 (HealthDay News) — The controversial new Alzheimer’s drug Aduhelm is creating something of a civil war in medicine, as health networks, hospitals, insurers and individual doctors weigh impending discussions with patients about whether they should take the medication. Many doctors believe the U.S. Food and DrugContinue Reading

Here’s some of HealthDay’s top stories for Friday, July 23: Arguing for & against approval of controversial Alzheimer’s drug. The FDA earlier this month gave its OK to the first new Alzheimer’s drug in years — despite its own panel voting 10-1 against approval. Now, some doctors and hospitals areContinue Reading

FRIDAY, July 23, 2021 (HealthDay News) — A drug that eases hallucinations in people with Parkinson’s disease may be able to do the same for those with dementia, a new clinical trial finds. The medication, called Nuplazid (pimavanserin), is already approved in the United States for treating hallucinations and delusionsContinue Reading

FRIDAY, July 23, 2021 (HealthDay News) — A traumatic brain injury (TBI) can cripple patients for the rest of their lives, but new research suggests that many people with moderate-to-severe TBI have better-than-expected long-term outcomes. The findings show that decisions about halting life-sustaining treatment for these patients should not beContinue Reading

FRIDAY, July 23, 2021 (HealthDay News) — Digestive issues are common after spinal cord injury and can lead to chronic constipation and incontinence. But robotic exoskeleton-assisted walking can improve matters in people with such injuries, researchers say. In an earlier survey, more than a third of men with spinal cordContinue Reading